|
V.M. Ermolenko, N.N. Filatova
New iron-containing phosphate-binding agents for the correction of hyperphosphatemia in patients with chronic kidney disease
|
№3-4 / 2016
|
|
M. M. Batushin
The use of ketoacids in chronic kidney disease
|
№3-4 / 2016
|
|
E.V. Bolotova, V.V. Yavlyanskaya, A.V. Dudnikova
Mineral and bone disorders in patients with chronic obstructive pulmonary disease combined with chronic kidney disease
|
№3-4 / 2016
|
|
D.O. Dragunov, A.V. Sokolova, T.V. Latyshev, G.P. Arutyunov
Prevalence of chronic kidney disease in comorbid patients
|
№3-4 / 2016
|
|
A.G. Burmagina, A.Yu. Nikolaev
Prehypertension as a risk factor for chronic kidney disease
|
№3-4 / 2016
|
|
O.N. Vetchinnikova
Modern strategy for erythropoiesis-stimulating therapy in chronic kidney disease
|
№2 / 2016
|
|
N.A. Mihajlova, S.V. Tishkina
Features in managing patients with chronic kidney disease and type 2 diabetes: the need for a multidisciplinary approach
|
№2 / 2016
|
|
K.S. Mil'chakov, V.V. Fomin
The study on the causes of resistance to antihypertensive therapy in patients with chronic glomerulonephritis
|
№2 / 2016
|
|
O.N. Kotenko, K.A. Evstigneeva
Implications of low-protein diet and ketoanalogues of essential amino acids' supplementation for cardiovascular and renal protection in patients with chronic kidney disease
|
№1 / 2016
|
|
O.N. Vetchinnikova, T.A. Britvin, S.Yu. Gulimova
Chronic kidney disease and hyperparathyroidism: primary and/or secondary? (a case report)
|
№1 / 2016
|
|
E.B. Mamedova, M.M. Batjushin, T.Ju. Bykovskaja
Health schools for patients: physicians’ perspective
|
№5-6 / 2015
|
|
G.G. Kijakbaev, V.V. Fomin, T.N. Krasnova
Clinical and pathogenetic associations in atrial fibrillation with concomitant chronic kidney disease
|
№5-6 / 2015
|
Русский
